NCT01690715终止不适用
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery
Hospital Sirio-Libanes1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年7月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Prognosis (disease graduation)
研究概览
简要总结
A retrospective study based on analysis of medical records of patients with hepatocellular carcinoma treated at the Hospital Sírio-Libanês (Sao Paulo-Brazil) between 2001 and 2011 with diagnosis confirmed by imaging or histological specimen underwent surgical resection with curative intent. The study aims to determine the prognostic value of vascular complications related to cancer and to evaluate the survival rate of these patients, comparing the data with those reported in the literature.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •hepatocellular carcinoma confirmed by imaging or histological specimen underwent surgical resection, with or without hepatic cirrhosis association;
- •presence of venous outflow obstruction, either by direct tumor invasion or thrombosis, on portal vein or one of its main vessels;
排除标准
- •Patients undergoing prior systemic treatment;
- •Patients presenting incomplete data that do not allow their classification according to the stratification models;
- •Patients whose information of progression or death can not be recovered;
结局指标
主要结局
Prognosis (disease graduation)
时间窗: 1 to 3 years
The carcinoma prognosis in the presence of vascular complications related to cancer, characterized by invasion or portal vein thrombosis.
次要结局
- Relation established between survival and degree of underlying liver dysfunction(1 to 3 years)
- Survival rate in years(1 to 3 years)
研究者
Frederico Perego Costa
Attending physician
Hospital Sirio-Libanes
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in EgyptHepatocellular CarcinomaNCT05047146Sadat City University530
Unknown
不适用
The Surveillance of Hepatocellular CarcinomaHepatocellular CarcinomaNCT05286099Chinese PLA General Hospital100
招募中
不适用
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular CarcinomaImmunotherapyCarcinoma, HepatocellularNCT06571396Qilu Hospital of Shandong University200
招募中
不适用
A Predictive Score for Arterial Thrombosis Associated With CancerCancerNCT05256329National and Kapodistrian University of Athens2,000
尚未招募
不适用
Clinical study of liver cancerCTRI/2023/02/049609Kasturba Medical College, Manipal